Kcnh2 | Rat | (+)-butaclamol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Butaclamol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | (-)-lobeline | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Lobeline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein] | CTD | PMID:12531891 |
Kcnh2 | Rat | (S)-duloxetine hydrochloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Duloxetine Hydrochloride results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | (S)-naringenin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Amiodarone promotes the reaction [naringenin results in decreased activity of KCNH2 protein] more ... | CTD | PMID:18057881 |
Kcnh2 | Rat | (S)-naringenin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | naringenin results in decreased activity of KCNH2 protein | CTD | PMID:18057881 |
Kcnh2 | Rat | (S)-nicotine | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Nicotine results in increased expression of KCNH2 mRNA | CTD | PMID:17997037 |
Kcnh2 | Rat | (Z)-chlorprothixene | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorprothixene results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [o and p'-DDT results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | o and p'-DDT results in decreased activity of KCNH2 protein | CTD | PMID:21362439 |
Kcnh2 | Rat | 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Hexetidine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 1,3-diphenylguanidine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [diphenylguanidine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | 1,3-diphenylguanidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | diphenylguanidine results in decreased activity of KCNH2 protein | CTD | PMID:21362439 |
Kcnh2 | Rat | 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethyl-2-butanol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | clobutinol results in decreased activity of KCNH2 protein | CTD | PMID:19034038 and PMID:28551711 |
Kcnh2 | Rat | 1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-2-phenothiazinyl]ethanone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | piperacetazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cloperastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | carbetapentane results in decreased activity of KCNH2 protein | CTD | PMID:19034038 |
Kcnh2 | Rat | 10H-phenothiazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | phenothiazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of KCNH2 mRNA | CTD | PMID:17555576 |
Kcnh2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Kcnh2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCNH2 mRNA | CTD | PMID:17942748 |
Kcnh2 | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of KCNH2 mRNA | CTD | PMID:17557909 |
Kcnh2 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of KCNH2 mRNA | CTD | PMID:17942748 |
Kcnh2 | Rat | 2,2-diphenylacetic acid (1-ethyl-3-piperidinyl) ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | piperidolate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Kcnh2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCNH2 mRNA | CTD | PMID:17942748 |
Kcnh2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KCNH2 mRNA | CTD | PMID:32109520 and PMID:33387578 |
Kcnh2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Verapamil results in decreased activity of KCNH2 protein] which results in decreased import of Thallium and Verapamil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 more ... |
Kcnh2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Verapamil results in decreased activity of KCNH2 protein | CTD | PMID:15671647 more ... |
Kcnh2 | Rat | 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dimethisoquin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 2-[2-(diethylamino)ethylamino]-2-phenylacetic acid 3-methylbutyl ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | camylofine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 2-[4-[3-[2-(trifluoromethyl)-9-thioxanthenylidene]propyl]-1-piperazinyl]ethanol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Flupenthixol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 2-[4-[4,4-bis(4-fluorophenyl)butyl]-1-piperazinyl]-N-(2,6-dimethylphenyl)acetamide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Lidoflazine results in decreased activity of KCNH2 protein | CTD | PMID:16278312 and PMID:28551711 |
Kcnh2 | Rat | 2-[4-[4,4-bis(4-fluorophenyl)butyl]-1-piperazinyl]-N-(2,6-dimethylphenyl)acetamide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Lidoflazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | 2-deoxy-D-glucose | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein more ... | CTD | PMID:12531891 |
Kcnh2 | Rat | 2-deoxy-D-glucose | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Deoxyglucose results in decreased activity of KCNH2 protein | CTD | PMID:12531891 |
Kcnh2 | Rat | 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benactyzine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | homosalate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:22676973 |
Kcnh2 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of KCNH2 mRNA | CTD | PMID:25172293 |
Kcnh2 | Rat | 3,3-diphenyl-N-(1-phenylethyl)-1-propanamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fendiline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 3,4-dimethoxybenzoic acid 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | mebeverine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 3,6-diaminoacridine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Proflavine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1H-benzimidazol-2-one | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benperidol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:19419905 |
Kcnh2 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of KCNH2 mRNA | CTD | PMID:18648102 |
Kcnh2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of KCNH2 mRNA | CTD | PMID:37611474 |
Kcnh2 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of KCNH2 gene | CTD | PMID:31683443 |
Kcnh2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KCNH2 mRNA | CTD | PMID:36041667 |
Kcnh2 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of KCNH2 gene | CTD | PMID:31601247 |
Kcnh2 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of KCNH2 exon | CTD | PMID:33297965 |
Kcnh2 | Rat | 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | SM 21 promotes the reaction [ifenprodil results in decreased activity of KCNH2 protein] | CTD | PMID:17460149 |
Kcnh2 | Rat | 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ifenprodil results in decreased activity of KCNH2 protein | CTD | PMID:17460149 and PMID:28551711 |
Kcnh2 | Rat | 4-amino-5-chloro-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | clebopride results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | beta-Cyclodextrins analog inhibits the reaction [Cisapride results in decreased activity of KCNH2 protein] more ... | CTD | PMID:11005845 more ... |
Kcnh2 | Rat | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride binds to KCNH2 protein | CTD | PMID:18701618 and PMID:19260734 |
Kcnh2 | Rat | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride affects the localization of KCNH2 protein mutant form | CTD | PMID:10531299 and PMID:11741928 |
Kcnh2 | Rat | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride results in decreased activity of KCNH2 protein | CTD | PMID:11741928 more ... |
Kcnh2 | Rat | 4-aminopyridine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | 4-Aminopyridine results in decreased activity of KCNH2 protein | CTD | PMID:19915712 |
Kcnh2 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of KCNH2 mRNA | CTD | PMID:28973697 |
Kcnh2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of KCNH2 mRNA | CTD | PMID:28973697 |
Kcnh2 | Rat | 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Triclabendazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | 7H-xanthine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Xanthine co-treated with XDH protein] results in decreased activity of KCNH2 protein | CTD | PMID:12531891 and PMID:14973143 |
Kcnh2 | Rat | 9H-xanthine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Xanthine co-treated with XDH protein] results in decreased activity of KCNH2 protein | CTD | PMID:12531891 and PMID:14973143 |
Kcnh2 | Rat | [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Mefloquine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Mefloquine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | acetylmethadol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Methadyl Acetate inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | aflatoxin B1 | decreases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of KCNH2 intron | CTD | PMID:30157460 |
Kcnh2 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of KCNH2 intron and aflatoxin B2 results in increased methylation of KCNH2 polyA tail | CTD | PMID:30157460 |
Kcnh2 | Rat | ajmaline | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ajmaline results in decreased activity of KCNH2 protein | CTD | PMID:15599706 and PMID:24052561 |
Kcnh2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein more ... | CTD | PMID:12531891 |
Kcnh2 | Rat | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of KCNH2 protein | CTD | PMID:31729781 |
Kcnh2 | Rat | aldehydo-D-glucose | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Glucose deficiency results in decreased activity of KCNH2 protein and Glucose results in decreased activity of KCNH2 protein | CTD | PMID:12531891 |
Kcnh2 | Rat | all-trans-retinoic acid | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of KCNH2 mRNA | CTD | PMID:15894607 and PMID:23830798 |
Kcnh2 | Rat | alpidem | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | alpidem results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | alverine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | alverine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | amantadine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Amantadine results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | amiodarone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Amiodarone binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of KCNH2 mRNA | CTD | PMID:22291062 |
Kcnh2 | Rat | amiodarone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Amiodarone results in decreased activity of KCNH2 protein | CTD | PMID:10208308 more ... |
Kcnh2 | Rat | amiodarone | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Amiodarone affects the activity of KCNH2 protein | CTD | PMID:22020101 |
Kcnh2 | Rat | amitriptyline | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Amitriptyline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 and PMID:21158687 |
Kcnh2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of KCNH2 mRNA | CTD | PMID:16483693 |
Kcnh2 | Rat | Ammothamnine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | oxymatrine inhibits the reaction [arsenic trioxide results in decreased localization of KCNH2 protein] | CTD | PMID:23103450 |
Kcnh2 | Rat | Ammothamnine | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | oxymatrine results in increased expression of KCNH2 protein | CTD | PMID:23103450 |
Kcnh2 | Rat | amorolfine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | amorolfine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | amperozide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | amperozide inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of KCNH2 mRNA | CTD | PMID:30779732 |
Kcnh2 | Rat | amsacrine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Amsacrine binds to and results in decreased activity of KCNH2 protein | CTD | PMID:15148258 |
Kcnh2 | Rat | aprindine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Aprindine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | aripiprazole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Aripiprazole inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | aripiprazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Aripiprazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | aristolochic acid A | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of KCNH2 mRNA | CTD | PMID:33212167 |
Kcnh2 | Rat | Arkin (TN) | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | vesnarinone results in decreased activity of KCNH2 protein | CTD | PMID:12695533 and PMID:17146843 |
Kcnh2 | Rat | Arkin (TN) | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene SNP affects the susceptibility to vesnarinone | CTD | PMID:12695533 |
Kcnh2 | Rat | arsane | affects expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic affects the expression of KCNH2 mRNA | CTD | PMID:18414638 |
Kcnh2 | Rat | arsenic atom | affects expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic affects the expression of KCNH2 mRNA | CTD | PMID:18414638 |
Kcnh2 | Rat | arsenous acid | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of KCNH2 protein | CTD | PMID:22977528 |
Kcnh2 | Rat | arsenous acid | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of and results in increased activity of KCNH2 protein more ... | CTD | PMID:23103450 more ... |
Kcnh2 | Rat | arsenous acid | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of KCNH2 mRNA | CTD | PMID:15070760 |
Kcnh2 | Rat | arsenous acid | increases degradation | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased degradation of KCNH2 protein | CTD | PMID:28521025 |
Kcnh2 | Rat | arsenous acid | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased activity of KCNH2 protein | CTD | PMID:25107562 |
Kcnh2 | Rat | arsenous acid | decreases localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased localization of KCNH2 protein | CTD | PMID:15213294 and PMID:23103450 |
Kcnh2 | Rat | astemizole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Astemizole results in decreased activity of KCNH2 protein | CTD | PMID:10422790 more ... |
Kcnh2 | Rat | astemizole | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Astemizole binds to KCNH2 gene polymorphism and Astemizole binds to KCNH2 protein | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | astemizole | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Astemizole affects the localization of KCNH2 protein mutant form | CTD | PMID:10531299 and PMID:11741928 |
Kcnh2 | Rat | astemizole | decreases activity | EXP | | 6480464 | Astemizole results in decreased activity of KCNH2 protein | CTD | PMID:11040061 |
Kcnh2 | Rat | astemizole | decreases activity | ISO | Kcnh2 (Mus musculus) | 6480464 | Astemizole results in decreased activity of KCNH2 protein | CTD | PMID:16723379 |
Kcnh2 | Rat | astemizole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Astemizole binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:10376921 more ... |
Kcnh2 | Rat | atorvastatin calcium | multiple interactions | EXP | | 6480464 | Berberine promotes the reaction [Atorvastatin results in decreased activity of KCNH2 protein] | CTD | PMID:30086269 |
Kcnh2 | Rat | atorvastatin calcium | decreases activity | EXP | | 6480464 | Atorvastatin results in decreased activity of KCNH2 protein | CTD | PMID:30086269 |
Kcnh2 | Rat | ATP | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Adenosine Triphosphate deficiency results in decreased activity of KCNH2 protein | CTD | PMID:12531891 |
Kcnh2 | Rat | atrazine | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Atrazine results in increased expression of KCNH2 mRNA | CTD | PMID:22378314 |
Kcnh2 | Rat | azaperone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Azaperone results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Azaspiracid | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | azaspiracid binds to and results in decreased activity of KCNH2 protein | CTD | PMID:22856456 |
Kcnh2 | Rat | azelastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | azelastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Azimilide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | azimilide results in decreased activity of KCNH2 protein | CTD | PMID:15821840 more ... |
Kcnh2 | Rat | Azimilide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Acids inhibits the reaction [azimilide results in decreased activity of KCNH2 protein] more ... | CTD | PMID:15821840 more ... |
Kcnh2 | Rat | Azoxymethane | multiple interactions | ISO | Kcnh2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNH2 mRNA | CTD | PMID:29950665 |
Kcnh2 | Rat | Balofloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | balofloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | benzalkonium chloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzalkonium Compounds results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | benzatropine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benztropine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | benzethonium chloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzethonium results in decreased activity of KCNH2 protein | CTD | PMID:21362439 more ... |
Kcnh2 | Rat | benzethonium chloride | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Benzethonium results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | benzo[a]pyrene | decreases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of KCNH2 3' UTR and Benzo(a)pyrene results in decreased methylation of KCNH2 exon | CTD | PMID:27901495 |
Kcnh2 | Rat | benzo[a]pyrene | affects methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of KCNH2 intron and Benzo(a)pyrene affects the methylation of KCNH2 polyA tail | CTD | PMID:30157460 |
Kcnh2 | Rat | benzo[a]pyrene | increases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of KCNH2 promoter | CTD | PMID:27901495 |
Kcnh2 | Rat | benzo[e]pyrene | increases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of KCNH2 intron | CTD | PMID:30157460 |
Kcnh2 | Rat | benzoic acid 2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl ester | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | benfluorex results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | benzydamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzydamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | bepridil | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Bepridil binds to and results in decreased activity of KCNH2 protein and Bepridil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:15272206 and PMID:21158687 |
Kcnh2 | Rat | bepridil | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Bepridil results in decreased activity of KCNH2 protein | CTD | PMID:15671647 and PMID:24052561 |
Kcnh2 | Rat | berberine | multiple interactions | EXP | | 6480464 | Berberine promotes the reaction [Atorvastatin results in decreased activity of KCNH2 protein] and Berberine promotes the reaction [Simvastatin results in decreased activity of KCNH2 protein] | CTD | PMID:30086269 |
Kcnh2 | Rat | berberine | decreases activity | EXP | | 6480464 | Berberine results in decreased activity of KCNH2 protein | CTD | PMID:30086269 |
Kcnh2 | Rat | betahistine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Betahistine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | bis(2-chloroethyl) sulfide | affects expression | EXP | | 6480464 | Mustard Gas affects the expression of KCNH2 mRNA | CTD | PMID:15651846 |
Kcnh2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KCNH2 mRNA | CTD | PMID:25181051 and PMID:33296240 |
Kcnh2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KCNH2 mRNA | CTD | PMID:36041667 |
Kcnh2 | Rat | bisphenol A | decreases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of KCNH2 gene | CTD | PMID:31601247 |
Kcnh2 | Rat | bisphenol AF | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol AF results in increased expression of KCNH2 mRNA | CTD | PMID:37611474 |
Kcnh2 | Rat | bisphenol F | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of KCNH2 mRNA | CTD | PMID:38685157 |
Kcnh2 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KCNH2 mRNA | CTD | PMID:36041667 |
Kcnh2 | Rat | bisphenol F | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of KCNH2 mRNA | CTD | PMID:37611474 |
Kcnh2 | Rat | bopindolol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | bopindolol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | brefeldin A | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Brefeldin A promotes the reaction [vandetanib results in decreased expression of KCNH2 protein modified form] | CTD | PMID:35680041 |
Kcnh2 | Rat | brefeldin A | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Brefeldin A results in decreased expression of KCNH2 protein modified form | CTD | PMID:35680041 |
Kcnh2 | Rat | bromhexine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Bromhexine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Bromocyclen | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | bromocyclen results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Bromperidol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | bromperidol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | brompheniramine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Brompheniramine results in decreased activity of KCNH2 protein | CTD | PMID:17010640 and PMID:17516459 |
Kcnh2 | Rat | buclizine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | buclizine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | buta-1,3-diene | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of KCNH2 mRNA | CTD | PMID:29038090 |
Kcnh2 | Rat | butanal | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of KCNH2 mRNA | CTD | PMID:26079696 |
Kcnh2 | Rat | butoconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | butoconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | C3-thiacarbocyanine cation | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dithiazanine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of KCNH2 promoter | CTD | PMID:22457795 |
Kcnh2 | Rat | calcitriol | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of KCNH2 mRNA | CTD | PMID:21592394 |
Kcnh2 | Rat | calcitriol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of KCNH2 mRNA | CTD | PMID:21592394 |
Kcnh2 | Rat | calcium atom | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [KCNH2 protein affects the abundance of Calcium] | CTD | PMID:11040061 |
Kcnh2 | Rat | calcium(0) | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [KCNH2 protein affects the abundance of Calcium] | CTD | PMID:11040061 |
Kcnh2 | Rat | cantharidin | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of KCNH2 mRNA | CTD | PMID:36907384 |
Kcnh2 | Rat | carbachol | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein mutant form affects the susceptibility to Carbachol | CTD | PMID:29574456 |
Kcnh2 | Rat | carbinoxamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | carbinoxamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | carmustine | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Carmustine results in decreased expression of KCNH2 mRNA | CTD | PMID:15980968 |
Kcnh2 | Rat | carvedilol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | carvedilol results in decreased activity of KCNH2 protein | CTD | PMID:11164846 and PMID:16314852 |
Kcnh2 | Rat | carvedilol | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | carvedilol affects the activity of KCNH2 protein | CTD | PMID:22020101 |
Kcnh2 | Rat | casticin | decreases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | casticin results in decreased expression of KCNH2 mRNA | CTD | PMID:28444820 |
Kcnh2 | Rat | cefotetan | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Cefotetan results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cepharanthine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cepharanthine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cetalkonium chloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cetalkonium chloride results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | CGP 52608 | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KCNH2 gene] | CTD | PMID:28238834 |
Kcnh2 | Rat | chloramine T | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | chloramine-T results in increased oxidation of and results in decreased activity of KCNH2 protein | CTD | PMID:17624316 |
Kcnh2 | Rat | chlordecone | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Chlordecone results in increased expression of KCNH2 mRNA | CTD | PMID:29980752 |
Kcnh2 | Rat | chlorobutanol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorobutanol binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:14527710 and PMID:20071423 |
Kcnh2 | Rat | chlorobutanol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorobutanol results in decreased activity of KCNH2 protein | CTD | PMID:14527710 |
Kcnh2 | Rat | chloroform | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chloroform results in decreased activity of KCNH2 protein | CTD | PMID:22024336 |
Kcnh2 | Rat | chlorphenamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorpheniramine results in decreased activity of KCNH2 protein | CTD | PMID:19885040 |
Kcnh2 | Rat | chlorphenamine | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorpheniramine affects the activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | chlorphenamine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorpheniramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | chlorpromazine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorpromazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | chlorpromazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorpromazine results in decreased activity of KCNH2 protein | CTD | PMID:15071359 and PMID:24052561 |
Kcnh2 | Rat | chlorpyrifos | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of KCNH2 mRNA | CTD | PMID:37019170 |
Kcnh2 | Rat | cholesterol | decreases localization | EXP | | 6480464 | Cholesterol results in decreased localization of KCNH2 protein | CTD | PMID:21525004 |
Kcnh2 | Rat | cibenzoline | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cifenline results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | ciclopirox | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | ciclopirox inhibits the reaction [Terfenadine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]] and ciclopirox promotes the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | cinacalcet | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Cinacalcet results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cinchocaine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dibucaine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cinchonine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cinchonine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | ciprofloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Ciprofloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | cisapride | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride affects the localization of KCNH2 protein mutant form | CTD | PMID:10531299 and PMID:11741928 |
Kcnh2 | Rat | cisapride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride results in decreased activity of KCNH2 protein | CTD | PMID:11741928 more ... |
Kcnh2 | Rat | cisapride | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisapride binds to KCNH2 protein | CTD | PMID:18701618 and PMID:19260734 |
Kcnh2 | Rat | cisapride | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | beta-Cyclodextrins analog inhibits the reaction [Cisapride results in decreased activity of KCNH2 protein] more ... | CTD | PMID:11005845 more ... |
Kcnh2 | Rat | cisplatin | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of KCNH2 | CTD | PMID:22020779 |
Kcnh2 | Rat | cisplatin | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of KCNH2 mRNA | CTD | PMID:27594783 |
Kcnh2 | Rat | cisplatin | increases response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 results in increased susceptibility to Cisplatin | CTD | PMID:22020779 |
Kcnh2 | Rat | clarithromycin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [KCNE2 protein mutant form binds to KCNH2 protein] which results in increased susceptibility to Clarithromycin | CTD | PMID:10219239 |
Kcnh2 | Rat | clarithromycin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Clarithromycin results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | clemastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Clemastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clofazimine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Clofazimine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clofedanol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | clofedanol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clomipramine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Clomipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | clopenthixol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Clopenthixol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clorotepine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | octoclothepine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Clotiapine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | clothiapine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clotrimazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Clotrimazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | clozapine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Clozapine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | cobalt dichloride | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of KCNH2 mRNA | CTD | PMID:22941251 |
Kcnh2 | Rat | codeine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Codeine results in decreased activity of KCNH2 protein | CTD | PMID:19034038 |
Kcnh2 | Rat | colforsin daropate hydrochloride | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:19419905 |
Kcnh2 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of KCNH2 mRNA | CTD | PMID:30556269 |
Kcnh2 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of KCNH2 mRNA | CTD | PMID:30556269 |
Kcnh2 | Rat | corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of KCNH2 mRNA | CTD | PMID:18835572 |
Kcnh2 | Rat | crizotinib | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | crizotinib results in decreased activity of KCNH2 protein | CTD | PMID:23707608 |
Kcnh2 | Rat | crystal violet | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Gentian Violet results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | curcumin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Curcumin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | cyamemazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | cyamemazine metabolite results in decreased activity of KCNH2 protein and cyamemazine results in decreased activity of KCNH2 protein | CTD | PMID:16494862 and PMID:18957172 |
Kcnh2 | Rat | cyclosporin A | decreases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of KCNH2 promoter | CTD | PMID:27989131 |
Kcnh2 | Rat | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of KCNH2 protein | CTD | PMID:31729781 |
Kcnh2 | Rat | D-glucose | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein more ... | CTD | PMID:12531891 |
Kcnh2 | Rat | D-glucose | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Glucose deficiency results in decreased activity of KCNH2 protein and Glucose results in decreased activity of KCNH2 protein | CTD | PMID:12531891 |
Kcnh2 | Rat | Danofloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | danofloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | dantrolene | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dantrolene results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | danuglipron | increases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | danuglipron results in increased activity of KCNH2 protein | CTD | PMID:39395609 |
Kcnh2 | Rat | darifenacin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | darifenacin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | daunorubicin | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Daunorubicin results in decreased expression of KCNH2 mRNA | CTD | PMID:26537877 and PMID:28940058 |
Kcnh2 | Rat | DDT | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | DDT results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | denopamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | denopamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | deptropine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dibenzheptropine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | desipramine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Desipramine results in decreased activity of KCNH2 protein | CTD | PMID:20211602 and PMID:24052561 |
Kcnh2 | Rat | desloratadine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [desloratadine co-treated with Loratadine] results in decreased activity of KCNH2 protein more ... | CTD | PMID:29143966 |
Kcnh2 | Rat | desloratadine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | desloratadine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 and PMID:29143966 |
Kcnh2 | Rat | desmethylastemizole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | desmethylastemizole binds to and results in decreased activity of KCNH2 protein | CTD | PMID:10376921 |
Kcnh2 | Rat | dexbrompheniramine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dexbrompheniramine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | dexetimide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dexetimide results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | dextran sulfate | multiple interactions | ISO | Kcnh2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNH2 mRNA | CTD | PMID:29950665 |
Kcnh2 | Rat | dextromethorphan | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dextromethorphan results in decreased activity of KCNH2 protein | CTD | PMID:19034038 |
Kcnh2 | Rat | diallyl trisulfide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | diallyl trisulfide results in decreased expression of and results in decreased activity of KCNH2 protein | CTD | PMID:24504171 |
Kcnh2 | Rat | diallyl trisulfide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | diallyl trisulfide results in decreased activity of KCNH2 protein | CTD | PMID:23272117 |
Kcnh2 | Rat | diarsenic trioxide | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of KCNH2 mRNA | CTD | PMID:15070760 |
Kcnh2 | Rat | diarsenic trioxide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of and results in increased activity of KCNH2 protein more ... | CTD | PMID:23103450 more ... |
Kcnh2 | Rat | diarsenic trioxide | decreases localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased localization of KCNH2 protein | CTD | PMID:15213294 and PMID:23103450 |
Kcnh2 | Rat | diarsenic trioxide | increases degradation | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased degradation of KCNH2 protein | CTD | PMID:28521025 |
Kcnh2 | Rat | diarsenic trioxide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased activity of KCNH2 protein | CTD | PMID:25107562 |
Kcnh2 | Rat | diarsenic trioxide | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of KCNH2 protein | CTD | PMID:22977528 |
Kcnh2 | Rat | Dibutyl phosphate | affects expression | ISO | KCNH2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of KCNH2 mRNA | CTD | PMID:37042841 |
Kcnh2 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of KCNH2 mRNA | CTD | PMID:21266533 |
Kcnh2 | Rat | Didecyldimethylammonium | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | didecyldimethylammonium results in decreased activity of KCNH2 protein | CTD | PMID:21362439 and PMID:28551711 |
Kcnh2 | Rat | Didecyldimethylammonium | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [didecyldimethylammonium results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | difloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | difloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | digoxin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Astemizole inhibits the reaction [Digoxin results in decreased activity of KCNH2 protein] more ... | CTD | PMID:19139152 |
Kcnh2 | Rat | digoxin | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene affects the susceptibility to Digoxin | CTD | PMID:19139152 |
Kcnh2 | Rat | digoxin | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Digoxin results in decreased expression of KCNH2 protein modified form | CTD | PMID:19139152 |
Kcnh2 | Rat | digoxin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Digoxin results in decreased activity of KCNH2 protein | CTD | PMID:19139152 |
Kcnh2 | Rat | dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Benzethonium results in decreased activity of KCNH2 protein | CTD | PMID:21362439 more ... |
Kcnh2 | Rat | dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Benzethonium results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KCNH2 mRNA | CTD | PMID:33729688 |
Kcnh2 | Rat | diphenylpyraline | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | diphenylpyraline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | dipyridamole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dipyridamole results in decreased activity of KCNH2 protein | CTD | PMID:17146843 |
Kcnh2 | Rat | disopyramide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Disopyramide results in decreased activity of KCNH2 protein | CTD | PMID:18724381 and PMID:28551711 |
Kcnh2 | Rat | disopyramide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Disopyramide binds to and results in decreased activity of KCNH2 protein | CTD | PMID:15272206 |
Kcnh2 | Rat | dithiazanine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dithiazanine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | dobutamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dobutamine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | dofetilide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Terfenadine co-treated with dofetilide] binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:10828461 more ... |
Kcnh2 | Rat | dofetilide | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | dofetilide binds to KCNH2 protein | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | dofetilide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dofetilide results in decreased activity of KCNH2 protein | CTD | PMID:10828461 more ... |
Kcnh2 | Rat | dolasetron | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dolasetron results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Domiphen bromide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | domiphen results in decreased activity of KCNH2 protein | CTD | PMID:21362439 and PMID:28551711 |
Kcnh2 | Rat | Domiphen bromide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [domiphen results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | domperidone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Domperidone results in decreased activity of KCNH2 protein | CTD | PMID:15640612 and PMID:28551711 |
Kcnh2 | Rat | domperidone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Domperidone inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | domperidone | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene SNP affects the susceptibility to Domperidone | CTD | PMID:21063774 |
Kcnh2 | Rat | doxepin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Doxepin inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | doxorubicin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Erythromycin affects the reaction [KCNH2 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:16086867 |
Kcnh2 | Rat | doxorubicin | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of KCNH2 mRNA | CTD | PMID:26537877 more ... |
Kcnh2 | Rat | doxorubicin | decreases response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16086867 |
Kcnh2 | Rat | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of KCNH2 mRNA | CTD | PMID:19915844 |
Kcnh2 | Rat | dronedarone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dronedarone results in decreased activity of KCNH2 protein | CTD | PMID:15618689 |
Kcnh2 | Rat | dronedarone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Potassium inhibits the reaction [dronedarone results in decreased activity of KCNH2 protein] | CTD | PMID:15618689 |
Kcnh2 | Rat | droperidol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Droperidol results in decreased activity of KCNH2 protein | CTD | PMID:16757186 and PMID:28551711 |
Kcnh2 | Rat | droperidol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Droperidol inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | dutasteride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Dutasteride results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | dyclonine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | dyclonine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | E-4031 | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [KCNE2 protein binds to KCNH2 protein] which results in increased susceptibility to E 4031 more ... | CTD | PMID:10219239 more ... |
Kcnh2 | Rat | E-4031 | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 results in decreased activity of KCNH2 protein | CTD | PMID:11741928 more ... |
Kcnh2 | Rat | E-4031 | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 affects the localization of KCNH2 protein mutant form | CTD | PMID:11741928 |
Kcnh2 | Rat | E-4031 | multiple interactions | EXP | | 6480464 | E 4031 inhibits the reaction [Progesterone results in decreased localization of KCNH2 protein] | CTD | PMID:21525004 |
Kcnh2 | Rat | E-4031 | increases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 results in increased activity of KCNH2 protein mutant form | CTD | PMID:10531299 |
Kcnh2 | Rat | E-4031 | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 binds to KCNH2 protein | CTD | PMID:19260734 |
Kcnh2 | Rat | Ebastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ebastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Eburnamonine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | eburnamonine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | econazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Econazole results in decreased activity of KCNH2 protein | CTD | PMID:21362439 |
Kcnh2 | Rat | econazole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Econazole results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | eletriptan | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | eletriptan results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | eliprodil | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | eliprodil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | emedastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | emedastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of KCNH2 mRNA | CTD | PMID:29391264 |
Kcnh2 | Rat | enoxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Enoxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | enrofloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Enrofloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | epinastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | epinastine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | erlotinib hydrochloride | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Erlotinib Hydrochloride affects the activity of KCNH2 protein | CTD | PMID:23707608 |
Kcnh2 | Rat | erlotinib hydrochloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Erlotinib Hydrochloride results in decreased activity of KCNH2 protein | CTD | PMID:35680041 |
Kcnh2 | Rat | erythromycin A | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Erythromycin binds to KCNH2 protein | CTD | PMID:18701618 |
Kcnh2 | Rat | erythromycin A | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Erythromycin results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | erythromycin A | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Erythromycin affects the reaction [KCNH2 protein results in decreased susceptibility to Doxorubicin] and Erythromycin binds to and results in decreased activity of KCNH2 protein | CTD | PMID:15272206 and PMID:16086867 |
Kcnh2 | Rat | ethanol | affects splicing | ISO | Kcnh2 (Mus musculus) | 6480464 | Ethanol affects the splicing of KCNH2 mRNA | CTD | PMID:30319688 |
Kcnh2 | Rat | ezogabine | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ezogabine affects the activity of KCNH2 protein | CTD | PMID:28641963 |
Kcnh2 | Rat | Febantel | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | febantel results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | fenoverine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | fenoverine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | fentanyl | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fentanyl results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Fexofenadine hydrochloride | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 inhibits the reaction [fexofenadine results in increased activity of KCNH2 protein mutant form] and fexofenadine inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein] | CTD | PMID:12070109 and PMID:28521025 |
Kcnh2 | Rat | Fexofenadine hydrochloride | increases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | fexofenadine results in increased activity of KCNH2 protein mutant form | CTD | PMID:12070109 |
Kcnh2 | Rat | fingolimod hydrochloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fingolimod Hydrochloride results in decreased activity of KCNH2 protein | CTD | PMID:25223691 |
Kcnh2 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of KCNH2 mRNA | CTD | PMID:18035473 |
Kcnh2 | Rat | flecainide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Flecainide binds to and results in decreased activity of KCNH2 protein | CTD | PMID:15272206 |
Kcnh2 | Rat | flecainide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Flecainide results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | fleroxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Fleroxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | flufenamic acid | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 inhibits the reaction [Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]] and Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:12359267 |
Kcnh2 | Rat | fluorescein (lactone form) | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluorescein results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | fluoxetine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluoxetine binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:11805215 more ... |
Kcnh2 | Rat | fluoxetine | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluoxetine results in decreased expression of KCNH2 protein modified form | CTD | PMID:35680041 |
Kcnh2 | Rat | fluoxetine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluoxetine results in decreased activity of KCNH2 protein | CTD | PMID:16967046 and PMID:24052561 |
Kcnh2 | Rat | fluoxetine | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein affects the susceptibility to Fluoxetine | CTD | PMID:16967046 |
Kcnh2 | Rat | fluoxetine | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluoxetine affects the localization of KCNH2 protein | CTD | PMID:16967046 |
Kcnh2 | Rat | flupenthixol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Flupenthixol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | flurazepam | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Flurazepam results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | fluvoxamine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Terfenadine co-treated with Fluvoxamine] binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:20071423 and PMID:21158687 |
Kcnh2 | Rat | fluvoxamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Fluvoxamine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | fomocaine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | fomocain results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | formoterol fumarate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Formoterol Fumarate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | fulvestrant | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of KCNH2 gene | CTD | PMID:31601247 |
Kcnh2 | Rat | gabapentin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | gabapentin results in decreased activity of KCNH2 protein | CTD | PMID:15716081 |
Kcnh2 | Rat | gatifloxacin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Gatifloxacin binds to and results in decreased activity of KCNH2 protein] which results in decreased export of Potassium and Gatifloxacin binds to and results in decreased activity of KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | geldanamycin | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | geldanamycin affects the localization of KCNH2 protein | CTD | PMID:12775586 |
Kcnh2 | Rat | geldanamycin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | geldanamycin results in decreased activity of KCNH2 protein | CTD | PMID:12775586 and PMID:24052561 |
Kcnh2 | Rat | geldanamycin | increases degradation | ISO | KCNH2 (Homo sapiens) | 6480464 | geldanamycin results in increased degradation of KCNH2 protein | CTD | PMID:12775586 |
Kcnh2 | Rat | geldanamycin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | geldanamycin inhibits the reaction [KCNH2 protein binds to HSP90AA1 protein] | CTD | PMID:12775586 |
Kcnh2 | Rat | geldanamycin | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | geldanamycin results in decreased expression of KCNH2 protein modified form | CTD | PMID:12775586 |
Kcnh2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of KCNH2 mRNA | CTD | PMID:33387578 |
Kcnh2 | Rat | ginsenoside Rb1 | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ginsenoside Rb1 affects the activity of KCNH2 protein | CTD | PMID:15842772 |
Kcnh2 | Rat | ginsenoside Rf | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ginsenoside Rf affects the activity of KCNH2 protein | CTD | PMID:15842772 |
Kcnh2 | Rat | ginsenoside Rg1 | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ginsenoside Rg1 affects the activity of KCNH2 protein | CTD | PMID:15842772 |
Kcnh2 | Rat | glucose | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Glucose deficiency results in decreased activity of KCNH2 protein and Glucose results in decreased activity of KCNH2 protein | CTD | PMID:12531891 |
Kcnh2 | Rat | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of KCNH2 protein | CTD | PMID:31729781 |
Kcnh2 | Rat | glucose | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein more ... | CTD | PMID:12531891 |
Kcnh2 | Rat | glyburide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Glyburide results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | Grepafloxacin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | grepafloxacin results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | Halofantrine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | halofantrine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | haloperidol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Haloperidol inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 and PMID:21158687 |
Kcnh2 | Rat | haloperidol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Haloperidol results in decreased activity of KCNH2 protein | CTD | PMID:15671647 more ... |
Kcnh2 | Rat | hydrogen peroxide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Hydrogen Peroxide inhibits the reaction [Astemizole results in decreased activity of KCNH2 protein mutant form] more ... | CTD | PMID:10828461 |
Kcnh2 | Rat | hydroxychloroquine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein] which results in decreased export of Potassium and Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | hydroxyzine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Hydroxyzine results in decreased activity of KCNH2 protein | CTD | PMID:19057127 |
Kcnh2 | Rat | ibogaine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ibogaine results in decreased activity of KCNH2 protein | CTD | PMID:23707769 and PMID:24307198 |
Kcnh2 | Rat | ICI 118551 | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ICI 118551 results in decreased activity of KCNH2 protein | CTD | PMID:16314852 |
Kcnh2 | Rat | ICI 118551 | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | ICI 118551 results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | CTD | PMID:15679475 |
Kcnh2 | Rat | idarubicin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Idarubicin results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | imipramine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Imipramine binds to and results in decreased activity of KCNH2 protein and Imipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | imipramine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Imipramine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | imipramine | decreases localization | EXP | | 6480464 | Imipramine results in decreased localization of KCNH2 protein | CTD | PMID:21525004 |
Kcnh2 | Rat | ipriflavone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ipriflavone results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | isoconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | isoconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | ivabradine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ivabradine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | ketoconazole | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ketoconazole affects the activity of KCNH2 protein mutant form | CTD | PMID:17965736 |
Kcnh2 | Rat | ketoconazole | decreases response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein mutant form results in decreased susceptibility to Ketoconazole | CTD | PMID:16542653 |
Kcnh2 | Rat | ketoconazole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Ketoconazole co-treated with desloratadine co-treated with Loratadine] results in decreased activity of KCNH2 protein more ... | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | ketoconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ketoconazole results in decreased activity of KCNH2 and Ketoconazole results in decreased activity of KCNH2 protein | CTD | PMID:16542653 more ... |
Kcnh2 | Rat | ketoconazole | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Ketoconazole affects the localization of KCNH2 and Ketoconazole affects the localization of KCNH2 protein mutant form | CTD | PMID:17965736 |
Kcnh2 | Rat | lamotrigine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | lamotrigine results in decreased activity of KCNH2 protein | CTD | PMID:15716081 |
Kcnh2 | Rat | lenperone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | lenperone results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | lidocaine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Lidocaine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | Liranaftate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | liranaftate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | lofepramine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Lofepramine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | lomefloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | lomefloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | loratadine | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Loratadine affects the activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | loratadine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [desloratadine co-treated with Loratadine] results in decreased activity of KCNH2 protein more ... | CTD | PMID:11705456 more ... |
Kcnh2 | Rat | loratadine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Loratadine results in decreased activity of KCNH2 protein | CTD | PMID:10604956 and PMID:29143966 |
Kcnh2 | Rat | lovastatin | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Lovastatin affects the activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | loxapine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Loxapine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | lubeluzole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | lubeluzole binds to and results in decreased activity of KCNH2 protein | CTD | PMID:29550817 |
Kcnh2 | Rat | malachite green cation | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | malachite green results in decreased activity of KCNH2 protein | CTD | PMID:21362439 |
Kcnh2 | Rat | malachite green cation | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [malachite green results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | manidipine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | manidipine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Maprotiline | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Maprotiline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | Mebhydrolin napadisilate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | diazoline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | mefloquine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Mefloquine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | mefloquine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Mefloquine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | mepyramine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Pyrilamine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | mepyramine | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Pyrilamine affects the activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | mercury atom | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Mercury results in increased expression of KCNH2 mRNA | CTD | PMID:16823088 |
Kcnh2 | Rat | mercury(0) | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Mercury results in increased expression of KCNH2 mRNA | CTD | PMID:16823088 |
Kcnh2 | Rat | mesoridazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Mesoridazine results in decreased activity of KCNH2 protein | CTD | PMID:17042915 |
Kcnh2 | Rat | methadone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Chlorobutanol promotes the reaction [Methadone results in decreased activity of KCNH2 protein] | CTD | PMID:14527710 |
Kcnh2 | Rat | methadone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Methadone results in decreased activity of KCNH2 protein | CTD | PMID:14527710 |
Kcnh2 | Rat | methapyrilene | increases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of KCNH2 intron | CTD | PMID:30157460 |
Kcnh2 | Rat | methdilazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | methdilazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | methiothepin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Methiothepin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of KCNH2 gene | CTD | PMID:35440735 |
Kcnh2 | Rat | methylmercury chloride | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of KCNH2 mRNA | CTD | PMID:28001369 |
Kcnh2 | Rat | methylseleninic acid | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | methylselenic acid results in increased expression of KCNH2 mRNA | CTD | PMID:18548127 |
Kcnh2 | Rat | metixene | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | methixene results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | metoclopramide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Metoclopramide results in decreased activity of KCNH2 protein | CTD | PMID:15640612 |
Kcnh2 | Rat | metoprolol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Metoprolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | CTD | PMID:15679475 |
Kcnh2 | Rat | metoprolol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Metoprolol results in decreased activity of KCNH2 protein | CTD | PMID:16314852 |
Kcnh2 | Rat | mexiletine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Mexiletine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | Mibefradil | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Mibefradil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | Mibefradil | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Mibefradil results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | miconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Miconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | mitoxantrone | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Mitoxantrone results in decreased expression of KCNH2 mRNA | CTD | PMID:26537877 and PMID:28940058 |
Kcnh2 | Rat | Mitragynine | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | mitragynine results in decreased expression of KCNH2 protein | CTD | PMID:27260674 |
Kcnh2 | Rat | Mitragynine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | mitragynine binds to and results in decreased activity of KCNH2 protein | CTD | PMID:27260674 |
Kcnh2 | Rat | Mizolastine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | mizolastine results in decreased activity of KCNH2 protein | CTD | PMID:11082114 and PMID:28551711 |
Kcnh2 | Rat | moxifloxacin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | moxifloxacin results in decreased activity of KCNH2 protein | CTD | PMID:24052561 and PMID:27553911 |
Kcnh2 | Rat | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [TGFB1 protein results in decreased expression of KCNH2 protein] | CTD | PMID:22853924 |
Kcnh2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein] | CTD | PMID:28521025 |
Kcnh2 | Rat | N-methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | bifemelane results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | nadifloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | nadifloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | naftifine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | naftifine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | nefazodone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nefazodone results in decreased activity of KCNH2 protein | CTD | PMID:24052561 and PMID:28551711 |
Kcnh2 | Rat | nefazodone | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nefazodone affects the activity of KCNH2 protein | CTD | PMID:26821276 |
Kcnh2 | Rat | nefazodone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | nefazodone binds to and results in decreased activity of KCNH2 protein | CTD | PMID:24374264 and PMID:26821276 |
Kcnh2 | Rat | nicotine | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Nicotine results in increased expression of KCNH2 mRNA | CTD | PMID:17997037 |
Kcnh2 | Rat | Nifekalant | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nifekalant results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Nifekalant | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nifekalant affects the activity of KCNH2 protein | CTD | PMID:22020101 |
Kcnh2 | Rat | Niflumic acid | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | E 4031 inhibits the reaction [Niflumic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]] and Niflumic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:12359267 |
Kcnh2 | Rat | Niguldipine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | niguldipine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | nilotinib | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nilotinib results in decreased activity of KCNH2 protein | CTD | PMID:23707608 |
Kcnh2 | Rat | nilotinib | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | nilotinib results in decreased expression of KCNH2 protein modified form | CTD | PMID:35680041 |
Kcnh2 | Rat | nilotinib | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | N-butanoylsphingosine inhibits the reaction [nilotinib results in decreased expression of KCNH2 protein modified form] and nilotinib results in decreased expression of and results in decreased activity of KCNH2 protein | CTD | PMID:35680041 |
Kcnh2 | Rat | nimesulide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | nimesulide results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | nimodipine | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [KCNH2 protein affects the abundance of Calcium] | CTD | PMID:11040061 |
Kcnh2 | Rat | Nitrovin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Nitrovin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | norfloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Norfloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | Norfluoxetine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | norfluoxetine results in decreased activity of KCNH2 protein | CTD | PMID:16967046 |
Kcnh2 | Rat | Norfluoxetine | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein affects the susceptibility to norfluoxetine | CTD | PMID:16967046 |
Kcnh2 | Rat | Norfluoxetine | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | norfluoxetine affects the localization of KCNH2 protein | CTD | PMID:16967046 |
Kcnh2 | Rat | nortriptyline | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Nortriptyline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | ofloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Ofloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | olanzapine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | olanzapine results in decreased activity of KCNH2 protein | CTD | PMID:16494862 |
Kcnh2 | Rat | olanzapine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | olanzapine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | oligomycin B | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | oligomycin B results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | Orbifloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | orbifloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | ouabain | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Ouabain results in decreased expression of KCNH2 protein modified form | CTD | PMID:19139152 |
Kcnh2 | Rat | ouabain | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Ouabain inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | ouabain | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ouabain results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | oxeladin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | oxeladin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | oxiconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | oxiconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | oxybuprocaine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | benoxinate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Oxyphencyclimine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | oxyphencyclimine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | paliperidone palmitate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Paliperidone Palmitate results in decreased activity of KCNH2 protein | CTD | PMID:21394035 |
Kcnh2 | Rat | palonosetron | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | palonosetron results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Panaxadiol | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | panaxadiol affects the activity of KCNH2 protein | CTD | PMID:15842772 |
Kcnh2 | Rat | Panaxatriol | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | panaxatriol affects the activity of KCNH2 protein | CTD | PMID:15842772 |
Kcnh2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of KCNH2 mRNA | CTD | PMID:33387578 |
Kcnh2 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of KCNH2 mRNA | CTD | PMID:32680482 |
Kcnh2 | Rat | parathiazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | pyrathiazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | pecazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | mepazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | pefloxacin | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Pefloxacin binds to KCNH2 protein | CTD | PMID:34058295 |
Kcnh2 | Rat | pentamidine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Pentamidine affects the localization of and affects the activity of KCNH2 protein more ... | CTD | PMID:15340016 more ... |
Kcnh2 | Rat | pentamidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Pentamidine results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | pentanal | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | pentanal results in increased expression of KCNH2 mRNA | CTD | PMID:26079696 |
Kcnh2 | Rat | pentobarbital | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Pentobarbital results in decreased activity of KCNH2 protein | CTD | PMID:11862331 |
Kcnh2 | Rat | perfluorooctanoic acid | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of KCNH2 mRNA | CTD | PMID:36326898 |
Kcnh2 | Rat | perhexiline | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Perhexiline binds to KCNH2 protein | CTD | PMID:18701618 |
Kcnh2 | Rat | Perhexiline maleate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | perhexiline maleate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | periciazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | periciazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | perphenazine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Perphenazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | perphenazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Perphenazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | phentolamine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Phentolamine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | phentolamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Phentolamine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | phenylephrine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Phenylephrine affects the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:19419905 |
Kcnh2 | Rat | phenytoin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Phenytoin results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | pimobendan | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | pimobendan results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | pimozide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Pimozide inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 and PMID:21158687 |
Kcnh2 | Rat | pimozide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Pimozide results in decreased activity of KCNH2 protein | CTD | PMID:15671647 and PMID:24052561 |
Kcnh2 | Rat | pizotifen | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Pizotyline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | potassium atom | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] more ... | CTD | PMID:11805215 more ... |
Kcnh2 | Rat | potassium atom | increases transport | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein results in increased transport of Potassium | CTD | PMID:11805215 more ... |
Kcnh2 | Rat | potassium atom | affects folding | ISO | KCNH2 (Homo sapiens) | 6480464 | Potassium deficiency affects the folding of KCNH2 protein | CTD | PMID:19139152 |
Kcnh2 | Rat | Prenylamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Prenylamine results in decreased activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | pridinol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | pridinol results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | probucol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Probucol results in decreased activity of KCNH2 protein SNP | CTD | PMID:15043509 |
Kcnh2 | Rat | procainamide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Procainamide binds to and results in decreased activity of KCNH2 protein | CTD | PMID:15272206 |
Kcnh2 | Rat | profenamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | profenamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | progesterone | multiple interactions | EXP | | 6480464 | 2-Hydroxypropyl-beta-cyclodextrin inhibits the reaction [Progesterone results in decreased localization of KCNH2 protein] more ... | CTD | PMID:21525004 |
Kcnh2 | Rat | promazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Promazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | propafenone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Propafenone analog binds to and results in decreased activity of KCNH2 protein more ... | CTD | PMID:21158687 and PMID:21175572 |
Kcnh2 | Rat | propafenone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Propafenone results in decreased activity of KCNH2 protein | CTD | PMID:18724381 and PMID:24052561 |
Kcnh2 | Rat | propafenone | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Propafenone affects the activity of KCNH2 protein | CTD | PMID:16278312 |
Kcnh2 | Rat | propanal | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of KCNH2 mRNA | CTD | PMID:26079696 |
Kcnh2 | Rat | propranolol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein] and Propranolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] | CTD | PMID:15679475 |
Kcnh2 | Rat | propranolol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Propranolol results in decreased activity of KCNH2 protein | CTD | PMID:16314852 |
Kcnh2 | Rat | pyridine | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | pyridine analog binds to KCNH2 protein | CTD | PMID:17768047 |
Kcnh2 | Rat | pyruvic acid | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Pyruvic Acid inhibits the reaction [[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein] | CTD | PMID:12531891 |
Kcnh2 | Rat | pyrvinium | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | pyrvinium results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | quetiapine fumarate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Quetiapine Fumarate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | quetiapine fumarate | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Quetiapine Fumarate inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | quifenadine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | quifenadine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | quinacrine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinacrine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | quinidine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Quinidine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium more ... | CTD | PMID:15821840 more ... |
Kcnh2 | Rat | quinidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinidine results in decreased activity of KCNH2 protein | CTD | PMID:11741928 more ... |
Kcnh2 | Rat | quinidine | affects activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinidine affects the activity of KCNH2 protein | CTD | PMID:22020101 |
Kcnh2 | Rat | quinidine | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinidine binds to KCNH2 protein | CTD | PMID:18701618 |
Kcnh2 | Rat | quinidine | affects localization | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinidine affects the localization of KCNH2 protein mutant form | CTD | PMID:11741928 |
Kcnh2 | Rat | quinidine | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene SNP affects the susceptibility to Quinidine | CTD | PMID:12695533 |
Kcnh2 | Rat | quinidine | decreases response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene mutant form results in decreased susceptibility to Quinidine | CTD | PMID:15673388 |
Kcnh2 | Rat | quinine | affects response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene SNP affects the susceptibility to Quinine | CTD | PMID:12695533 |
Kcnh2 | Rat | quinine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Quinine results in decreased activity of KCNH2 protein | CTD | PMID:12695533 and PMID:28551711 |
Kcnh2 | Rat | ractopamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ractopamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | radicicol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | monorden results in decreased activity of KCNH2 protein | CTD | PMID:12775586 |
Kcnh2 | Rat | radicicol | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | monorden results in decreased expression of KCNH2 protein modified form | CTD | PMID:12775586 |
Kcnh2 | Rat | ranolazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Ranolazine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | ranolazine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Ranolazine inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein] | CTD | PMID:28521025 |
Kcnh2 | Rat | reactive oxygen species | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [iron(III)-ascorbic acid complex results in increased abundance of Reactive Oxygen Species] affects the reaction [KCNH2 protein affects the transport of Potassium] and [iron(III)-ascorbic acid complex results in increased abundance of Reactive Oxygen Species] which affects the activity of KCNH2 protein | CTD | PMID:9326673 |
Kcnh2 | Rat | rescinnamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | rescinnamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | reserpine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Reserpine results in decreased activity of KCNH2 protein | CTD | PMID:21362439 and PMID:28551711 |
Kcnh2 | Rat | reserpine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Reserpine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium | CTD | PMID:21362439 |
Kcnh2 | Rat | resveratrol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | resveratrol inhibits the reaction [arsenic trioxide results in decreased activity of KCNH2 protein] | CTD | PMID:25107562 |
Kcnh2 | Rat | risperidone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Risperidone inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | ritanserin | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Ritanserin inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | Robenidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Robenidine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | rolipram | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Rolipram results in decreased activity of KCNH2 protein | CTD | PMID:17146843 |
Kcnh2 | Rat | rose bengal | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Rose Bengal results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | rosuvastatin calcium | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Rosuvastatin Calcium results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | rotenone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Rotenone results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | rotenone | multiple interactions | EXP | | 6480464 | [3-bromo-2-oxopropionic acid co-treated with Rotenone] results in decreased expression of KCNH2 protein | CTD | PMID:31585160 |
Kcnh2 | Rat | rotigotine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | rotigotine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | rubidium atom | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Rubidium inhibits the reaction [Gramicidin results in decreased expression of KCNH2 protein modified form] | CTD | PMID:19139152 |
Kcnh2 | Rat | Salmeterol xinafoate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Salmeterol Xinafoate results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | sarin | increases expression | EXP | | 6480464 | Sarin results in increased expression of KCNH2 mRNA | CTD | PMID:16733813 |
Kcnh2 | Rat | sertaconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | sertaconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | sertindole | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | sertindole inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | sertindole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | sertindole results in decreased activity of KCNH2 protein | CTD | PMID:16278312 and PMID:24052561 |
Kcnh2 | Rat | sertraline | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Sertraline results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | simvastatin | decreases localization | EXP | | 6480464 | Simvastatin results in decreased localization of KCNH2 protein | CTD | PMID:21525004 |
Kcnh2 | Rat | simvastatin | decreases activity | EXP | | 6480464 | Simvastatin results in decreased activity of KCNH2 protein | CTD | PMID:30086269 |
Kcnh2 | Rat | simvastatin | multiple interactions | EXP | | 6480464 | Berberine promotes the reaction [Simvastatin results in decreased activity of KCNH2 protein] | CTD | PMID:30086269 |
Kcnh2 | Rat | SNC-80 | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | 4-(alpha-(4-allyl-2 more ... | CTD | PMID:28551711 |
Kcnh2 | Rat | sodium arsenite | affects methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of KCNH2 gene | CTD | PMID:28589171 |
Kcnh2 | Rat | sodium atom | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Sodium deficiency inhibits the reaction [Digoxin results in decreased expression of KCNH2 protein] | CTD | PMID:19139152 |
Kcnh2 | Rat | sodium cyanide | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Sodium Cyanide inhibits the reaction [Glucose results in decreased activity of KCNH2 protein] | CTD | PMID:12531891 |
Kcnh2 | Rat | sorafenib | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | sorafenib results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | sotalol | decreases response to substance | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 gene mutant form results in decreased susceptibility to Sotalol | CTD | PMID:15673388 |
Kcnh2 | Rat | sotalol | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Sotalol results in decreased activity of KCNH2 protein | CTD | PMID:16757186 more ... |
Kcnh2 | Rat | sotalol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Potassium inhibits the reaction [Sotalol results in decreased activity of KCNH2 protein] | CTD | PMID:16960444 |
Kcnh2 | Rat | sotalol | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Sotalol analog binds to KCNH2 protein | CTD | PMID:18701618 |
Kcnh2 | Rat | strychnine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Strychnine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | sulforaphane | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | sulforaphane results in increased expression of KCNH2 mRNA | CTD | PMID:30529165 |
Kcnh2 | Rat | sunitinib | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | sunitinib results in decreased activity of KCNH2 protein | CTD | PMID:21906609 more ... |
Kcnh2 | Rat | Syrosingopine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | syrosingopine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | tacrine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Tacrine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | tamoxifen | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Tamoxifen results in decreased activity of KCNH2 protein] which results in decreased import of Thallium more ... | CTD | PMID:15272206 more ... |
Kcnh2 | Rat | tamoxifen | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Tamoxifen results in decreased activity of KCNH2 protein | CTD | PMID:21362439 and PMID:28551711 |
Kcnh2 | Rat | tamoxifen | affects expression | ISO | Kcnh2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of KCNH2 mRNA | CTD | PMID:17555576 |
Kcnh2 | Rat | tazarotene | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | tazarotene results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | terbinafine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | terbinafine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | terconazole | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | terconazole results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Terfenadine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | 2-(4-(2-(3 more ... | CTD | PMID:10828461 more ... |
Kcnh2 | Rat | Terfenadine | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | Terfenadine binds to KCNH2 protein | CTD | PMID:18701618 and PMID:19260734 |
Kcnh2 | Rat | Terfenadine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Terfenadine results in decreased activity of KCNH2 protein | CTD | PMID:10422790 more ... |
Kcnh2 | Rat | terodiline | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | terodiline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | testosterone | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of KCNH2 mRNA | CTD | PMID:21592394 |
Kcnh2 | Rat | testosterone | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of KCNH2 mRNA | CTD | PMID:21592394 |
Kcnh2 | Rat | tetramethrin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | tetramethrin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | thallium | increases transport | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein results in increased transport of Thallium and KCNH2 results in increased transport of Thallium | CTD | PMID:19583963 and PMID:21158687 |
Kcnh2 | Rat | thallium | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | 2-(4-(2-(3 more ... | CTD | PMID:19583963 more ... |
Kcnh2 | Rat | thallium | increases import | ISO | KCNH2 (Homo sapiens) | 6480464 | KCNH2 protein results in increased import of Thallium | CTD | PMID:21158688 |
Kcnh2 | Rat | thioridazine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Thioridazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | thioridazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Thioridazine results in decreased activity of KCNH2 protein | CTD | PMID:15671647 more ... |
Kcnh2 | Rat | tiamulin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | tiamulin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | tifenamil | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | thiphenamil results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | tipepidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | tipepidine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | tiquizium bromide | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | thiaton results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | titanium dioxide | multiple interactions | ISO | Kcnh2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNH2 mRNA | CTD | PMID:29950665 |
Kcnh2 | Rat | titanium dioxide | decreases methylation | ISO | Kcnh2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of KCNH2 gene | CTD | PMID:35295148 |
Kcnh2 | Rat | tolcapone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | tolcapone results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | topiramate | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | topiramate results in decreased activity of KCNH2 protein | CTD | PMID:15716081 |
Kcnh2 | Rat | toremifene | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Toremifene results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | trazodone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Trazodone results in decreased activity of KCNH2 protein | CTD | PMID:15740727 more ... |
Kcnh2 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of KCNH2 mRNA | CTD | PMID:33387578 |
Kcnh2 | Rat | trichostatin A | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of KCNH2 mRNA | CTD | PMID:24935251 |
Kcnh2 | Rat | trifluoperazine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Trifluoperazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:21158687 |
Kcnh2 | Rat | trifluperidol | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Trifluperidol inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | triflupromazine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Triflupromazine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Tripelennamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Tripelennamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | triphenyl phosphate | affects expression | ISO | KCNH2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of KCNH2 mRNA | CTD | PMID:37042841 |
Kcnh2 | Rat | triprolidine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Triprolidine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | triptonide | increases expression | ISO | Kcnh2 (Mus musculus) | 6480464 | triptonide results in increased expression of KCNH2 mRNA | CTD | PMID:33045310 |
Kcnh2 | Rat | Triton X-100 | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Octoxynol results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | Valnemulin | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | valnemulin results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | valproic acid | increases methylation | ISO | KCNH2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of KCNH2 gene | CTD | PMID:29154799 |
Kcnh2 | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of KCNH2 mRNA | CTD | PMID:33150595 |
Kcnh2 | Rat | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of KCNH2 promoter | CTD | PMID:33150595 |
Kcnh2 | Rat | valproic acid | affects expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of KCNH2 mRNA | CTD | PMID:25979313 |
Kcnh2 | Rat | valproic acid | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of KCNH2 mRNA | CTD | PMID:23179753 and PMID:29154799 |
Kcnh2 | Rat | vandetanib | affects binding | ISO | KCNH2 (Homo sapiens) | 6480464 | vandetanib binds to KCNH2 protein | CTD | PMID:29630634 |
Kcnh2 | Rat | vandetanib | decreases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | vandetanib results in decreased expression of KCNH2 protein modified form | CTD | PMID:35680041 |
Kcnh2 | Rat | vandetanib | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Brefeldin A promotes the reaction [vandetanib results in decreased expression of KCNH2 protein modified form] more ... | CTD | PMID:35680041 |
Kcnh2 | Rat | vanoxerine dihydrochloride | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | vanoxerine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | venlafaxine hydrochloride | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Venlafaxine Hydrochloride results in decreased activity of KCNH2 protein | CTD | PMID:21158687 |
Kcnh2 | Rat | verapamil | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | [Verapamil results in decreased activity of KCNH2 protein] which results in decreased import of Thallium and Verapamil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 more ... |
Kcnh2 | Rat | verapamil | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Verapamil results in decreased activity of KCNH2 protein | CTD | PMID:15671647 more ... |
Kcnh2 | Rat | vincamine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Vincamine results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | Vinpocetine | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | vinpocetine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] | CTD | PMID:19583963 |
Kcnh2 | Rat | Vinpocetine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | vinpocetine results in decreased activity of KCNH2 protein | CTD | PMID:17146843 |
Kcnh2 | Rat | vitamin E | multiple interactions | ISO | KCNH2 (Homo sapiens) | 6480464 | Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein] | CTD | PMID:14973143 |
Kcnh2 | Rat | vitamin E | increases expression | ISO | KCNH2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of KCNH2 mRNA | CTD | PMID:19244175 |
Kcnh2 | Rat | xaliproden | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | xaliproden results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | zimeldine | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | Zimeldine results in decreased activity of KCNH2 protein | CTD | PMID:24052561 |
Kcnh2 | Rat | zinc pyrithione | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | pyrithione zinc results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |
Kcnh2 | Rat | ziprasidone | decreases activity | ISO | KCNH2 (Homo sapiens) | 6480464 | ziprasidone results in decreased activity of KCNH2 protein | CTD | PMID:28551711 |